semaglutide gastroparesis class action in west virginia Makers of Mounjaro and Ozempic Hit With Lawsuit Over Weight Loss Complications glp-1 gastroparesis lawsuit in west

Zepbound (Tirzepatide): A dual GIP/GLP-1 agonist that addresses two hormones for enhanced weight loss effectiveness

Your body's natural circadian rhythm influences hunger hormones and metabolism throughout the day

A 2025 database study published in the International Journal of Impotence Research found that non-diabetic obese men prescribed semaglutide for weight loss had a 4.5-fold higher risk of erectile dysfunction and nearly double the risk of testosterone deficiency compared to matched controls not taking the drug

Headaches associated with semaglutide are typically mild to moderate in severity and often diminish as the body adjusts to the medication